|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,215.65 INR | +0.51% |
|
-2.65% | -4.36% |
Company Valuation: Dr. Reddy's Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 749,317 | 714,500 | 767,655 | 1,024,969 | 953,168 | 1,012,067 | - | - |
| Change | - | -4.65% | 7.44% | 33.52% | -7.01% | 6.18% | - | - |
| Enterprise Value (EV) 1 | 745,052 | 703,980 | 719,330 | 960,383 | 928,633 | 979,861 | 950,230 | 923,435 |
| Change | - | -5.51% | 2.18% | 33.51% | -3.31% | 5.52% | -3.02% | -2.82% |
| P/E ratio | 39.2x | 30.4x | 17.1x | 18.4x | 16.9x | 19.4x | 21.9x | 19.1x |
| PBR | 4.29x | 3.76x | 3.33x | 3.63x | 2.86x | 2.71x | 2.46x | 2.24x |
| PEG | - | 1.3x | 0.2x | 0.8x | 13.12x | -2.54x | -1.9x | 1.3x |
| Capitalization / Revenue | 3.95x | 3.33x | 3.11x | 3.67x | 2.93x | 2.96x | 2.9x | 2.65x |
| EV / Revenue | 3.93x | 3.28x | 2.92x | 3.44x | 2.85x | 2.86x | 2.72x | 2.42x |
| EV / EBITDA | 15.7x | 13.7x | 11.1x | 12.1x | 10.8x | 11.9x | 12.5x | 10.8x |
| EV / EBIT | 23.3x | 20.5x | 13.8x | 14.8x | 13.4x | 15.4x | 17x | 14x |
| EV / FCF | 28.7x | 52.3x | 15.1x | 33.1x | 49.1x | 23x | 20.9x | 21.3x |
| FCF Yield | 3.48% | 1.91% | 6.61% | 3.02% | 2.04% | 4.35% | 4.79% | 4.69% |
| Dividend per Share 2 | 5 | 6 | 8 | 8 | 8 | 9.018 | 8.903 | 9.662 |
| Rate of return | 0.55% | 0.7% | 0.87% | 0.65% | 0.7% | 0.74% | 0.73% | 0.79% |
| EPS 2 | 23.03 | 28.34 | 54.18 | 66.92 | 67.78 | 62.6 | 55.45 | 63.79 |
| Distribution rate | 21.7% | 21.2% | 14.8% | 12% | 11.8% | 14.4% | 16.1% | 15.1% |
| Net sales 1 | 189,722 | 214,391 | 246,697 | 279,164 | 325,535 | 342,228 | 349,339 | 381,562 |
| EBITDA 1 | 47,480 | 51,400 | 64,559 | 79,481 | 86,236 | 82,060 | 76,162 | 85,459 |
| EBIT 1 | 31,977 | 34,277 | 52,057 | 64,781 | 69,178 | 63,467 | 55,790 | 65,845 |
| Net income 1 | 19,149 | 23,568 | 45,073 | 55,779 | 56,544 | 51,833 | 46,481 | 53,753 |
| Net Debt 1 | -4,265 | -10,520 | -48,325 | -64,586 | -24,535 | -32,206 | -61,837 | -88,633 |
| Reference price 2 | 903.12 | 861.08 | 924.30 | 1,231.03 | 1,144.05 | 1,215.65 | 1,215.65 | 1,215.65 |
| Nbr of stocks (in thousands) | 829,699 | 829,771 | 830,526 | 832,611 | 833,152 | 832,532 | - | - |
| Announcement Date | 5/14/21 | 5/19/22 | 5/10/23 | 5/7/24 | 5/9/25 | - | - | - |
1INR in Million2INR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 19.32x | 2.85x | 11.88x | 0.75% | 11.16B | ||
| 46.47x | 15.39x | 34.15x | 0.55% | 952B | ||
| 19.66x | 5.52x | 15.38x | 2.53% | 492B | ||
| 74.58x | 7.29x | 17.31x | 2.97% | 389B | ||
| 19.48x | 4.96x | 12.35x | 2.9% | 363B | ||
| 28.79x | 5.41x | 16.04x | 1.69% | 296B | ||
| 14.2x | 4.62x | 9.95x | 2.93% | 274B | ||
| 19.94x | 5.27x | 12.38x | 2.87% | 273B | ||
| 16.55x | 5.85x | 12.09x | 3.05% | 264B | ||
| 25.78x | 6.06x | 10.38x | 2.93% | 176B | ||
| Average | 28.48x | 6.32x | 15.19x | 2.32% | 349.03B | |
| Weighted average by Cap. | 33.51x | 8.29x | 19.28x | 2.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- DRREDDY Stock
- Valuation Dr. Reddy's Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















